Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: J Invest Dermatol. 2018 Aug 18;139(2):360–368. doi: 10.1016/j.jid.2018.07.030

Figure 4. MicroCT analysis does not reveal changes in trabecular bone microarchitecture in the Abcc6−/− mice treated with 75 mg/kg/day SBI-425.

Figure 4.

Note the distinct differences between male and female mice in each group. Changes were not found in Abcc6−/− mice (Group B) compared to wild type C57BL/6J mice (Group A). Treatment with 75 mg/kg/day SBI-425 in the Abcc6−/− mice (Group D) did not alter the femoral microarchitecture as compared to Abcc6−/− control mice (Group B). n = 3-5 per sex in each group. Their respective quantitative data were detailed in Table 2.